Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$7,000.00
Sep 5, 2024
Grant as part of the Policy Dialogue Program to Chippewas of the Thames First Nation to assist in preparing for and engaging in participation activities associated with the ongoing Review of Legislative, Regulatory, and Policy Development Processes.
$7,000.00
Sep 5, 2024
Grant as part of the Policy Dialogue Program to Chippewas of the Thames First Nation to assist in preparing for and engaging in participation activities associated with the ongoing Review of Legislative, Regulatory, and Policy Development Processes.
$7,000.00
Sep 5, 2024
Grant as part of the Policy Dialogue Program to Chippewas of the Thames First Nation to assist in preparing for and engaging in participation activities associated with the ongoing Review of Legislative, Regulatory, and Policy Development Processes.
$8,000.00
Sep 5, 2024
Grant as part of the Policy Dialogue Program to Interlake Reserves Tribal Council to assist in preparing for and engaging in participation activities associated with the ongoing Review of Legislative, Regulatory, and Policy Development Processes.
$8,000.00
Sep 5, 2024
Grant as part of the Policy Dialogue Program to Interlake Reserves Tribal Council to assist in preparing for and engaging in participation activities associated with the ongoing Review of Legislative, Regulatory, and Policy Development Processes.
$8,000.00
Sep 5, 2024
Grant as part of the Policy Dialogue Program to Interlake Reserves Tribal Council to assist in preparing for and engaging in participation activities associated with the ongoing Review of Legislative, Regulatory, and Policy Development Processes.
$1,222,429.00
Sep 5, 2024
Other
2425-HQ-000020
2425-HQ-000020
To strengthen responses to drug and substance use issues in Canada.
$1,148,357.00
Sep 5, 2024
Other
2425-HQ-000020
2425-HQ-000020
To strengthen responses to drug and substance use issues in Canada.
$204,387.00
Sep 5, 2024
Not-for-profit organization or charity
Non-Viral Gene Therapy for Myotubular Myopathy: Skeletal Muscle Targeted
Lipid Nanoparticle-Mediated Delivery of the MTM1 Gene to Restore Muscle
Function.
1025235
Myotubular myopathy is a severe congenital disorder marked by muscle
weakness and hypotonia due to mutations in the MTM1 gene, which encodes
myotubularin. This protein is crucial for muscle cell maintenance and repair, and
its deficiency disrupts these processes, causing significant muscle dysfunction.
Current treatments are symptomatic and fail to address the genetic cause,
necessitating therapies that target the root of the disease. Gene therapy,
particularly with viral vectors, shows promise but has limitations such as immune
responses and high costs. Recent safety setbacks in AAV8-MTM1 gene therapy
trials underscore the need for alternative delivery methods. Lipid nanoparticles
(LNPs), successful in mRNA vaccine delivery, offer a promising non-viral
alternative. NRC’s proprietary LNPs, targeted to skeletal muscle cells, present an
innovative solution. This project hypothesizes that LNP-mediated delivery of a
functional MTM1 gene can restore myotubularin function, enhancing muscle
strength and function in myotubular myopathy patients without the risks
associated with viral vectors.
$23,000.00
Sep 5, 2024
For-profit organization
YOUTH - Hiring of a B2B sales representative
1021523
The project aims to hire a young technology services sales representative in North America.